Vascular Risk Foundation (Varifo), Olten, Switzerland.
BAD Gesundheitsvorsorge und Sicherheitstechnik GmbH, Bonn, Germany.
Prev Med. 2021 Jun;147:106525. doi: 10.1016/j.ypmed.2021.106525. Epub 2021 Mar 18.
A large number of cardiovascular events occur in seemingly healthy individuals. Atherosclerosis imaging can improve the outcome and treatment regime of such subjects. We aim to assess the predictive value of atherosclerosis imaging beyond traditional risk calculators in subjects aged 40-65 years. We compared PROCAM, SCORE and FRAM with carotid ultrasound (total plaque area, TPA) and arterial age (AA) was calculated in subjects without known cardiovascular diseases. Follow-up was obtained by phone or mail. In 2842 subjects (age 50 ± 8, 38% women) 154 (5.4%) cardiovascular events occurred (ASCVD: 41 myocardial infarctions, 16 strokes or TIA, 21 CABG, 41 PTCA, 35 coronary artery disease defined by invasive angiography) during a mean follow-up time of 5.9 (1-12) years. PROCAM risk was 5 ± 6%, SCORE risk 1.3 ± 1.6% and FRAM 10 ± 6%. Both for the primary outcome (AMI, STROKE/TIA, CABG) and the secondary outcome (adding CAD and PTCA) hazards increased significantly for TPA tertiles and AA groups between 1.4 (0.1-16.1) and 21.4 (2.8-163.6) after adjustment for risk factors (age, smoke, sex, systolic BP, lipids, BMI, medication in Model 1) and after adjustment for results from PROCAM, SCORE and FRAM (Model 2). Model performance was statistically improved regarding model fit in all models using TPA and AA. Net reclassification improvement (NRI) for PROCAM and SCORE using TPA tertiles or AA age groups increased significantly between 30% to 48%. TPA and AA added prognostic information to conventional risk equations, supporting the assessment of ASCVD risk with carotid ultrasound in subjects aged 40-65 years.
大量心血管事件发生在看似健康的个体中。动脉粥样硬化成像可以改善这些患者的预后和治疗方案。我们旨在评估动脉粥样硬化成像在 40-65 岁人群中对传统风险计算器的预测价值。我们比较了 PROCAM、SCORE 和 FRAM 与颈动脉超声(总斑块面积,TPA),并计算了无已知心血管疾病患者的动脉年龄(AA)。通过电话或邮件进行随访。在 2842 名受试者(年龄 50±8 岁,38%为女性)中,154 名(5.4%)发生心血管事件(ASCVD:41 例心肌梗死、16 例卒中和 TIA、21 例 CABG、41 例 PTCA、35 例经血管造影定义的冠心病),平均随访时间为 5.9(1-12)年。PROCAM 风险为 5±6%,SCORE 风险为 1.3±1.6%,FRAM 风险为 10±6%。对于主要结局(AMI、STROKE/TIA、CABG)和次要结局(增加 CAD 和 PTCA),在调整危险因素(年龄、吸烟、性别、收缩压、血脂、BMI、药物)后,TPA 三分位组和 AA 组的风险比显著增加(1.4(0.1-16.1)至 21.4(2.8-163.6)),在调整 PROCAM、SCORE 和 FRAM 的结果后(模型 2)。在所有使用 TPA 和 AA 的模型中,模型拟合的统计学均有所改善。使用 TPA 三分位或 AA 年龄组,PROCAM 和 SCORE 的净重新分类改善(NRI)显著增加 30%至 48%。TPA 和 AA 为传统风险方程提供了预后信息,支持在 40-65 岁人群中使用颈动脉超声评估 ASCVD 风险。